{"database": "lobbying", "table": "lobbying_activities", "rows": [[1918492, "14454e03-c07e-436d-ba78-01ce793d0c42", "Q4", "THE OB-C GROUP, LLC", 29802, "EMERGENT BIOSOLUTIONS INC.", 2016, "fourth_quarter", "DIS", "H.R. 3299: The Strengthening Public Health Emergency Response Act of 2015\nS2055: Medical Countermeasure Innovation Act of 2015", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-01-18T14:55:41-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1918492"], "units": {}, "query_ms": 0.29563601128757, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}